Royalty Pharma plc (RPRX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $2.38B | +5.1% |
| 2024 | $2.26B | -3.9% |
| 2023 | $2.35B | +5.2% |
| 2022 | $2.24B | -2.3% |
| 2021 | $2.29B | +7.9% |
| 2020 | $2.12B | +17.0% |
| 2019 | $1.81B | +1.1% |
| 2018 | $1.79B | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $2.38B | +5.1% |
| 2024 | $2.26B | -3.9% |
| 2023 | $2.35B | +5.2% |
| 2022 | $2.24B | -2.3% |
| 2021 | $2.29B | +7.9% |
| 2020 | $2.12B | +17.0% |
| 2019 | $1.81B | +1.1% |
| 2018 | $1.79B | — |